On-demand Activity
Activity Overview
Please read the following information about this continuing pharmacy education (CPE) activity before accessing the presentations using the link located at the bottom of this page.
Release Date: February 18, 2014 Expiration Date: May 1, 2015
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #0204-0000-13-481-H01-P).
Methods and Format
This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2 hours. This activity is provided free of charge.
Target Audience
This continuing pharmacy education activity was planned to meet the needs of pharmacists in a variety of practice settings, including large and small health systems, ambulatory care clinics, managed care organizations, and academia. This activity would be particularly beneficial for pharmacists, clinical specialists, pharmacy managers, leaders, and educators who are interested in infectious diseases.
Activity Content
Applying antimicrobial stewardship principles to effectively treat community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) is critical. Another concern related to treating patients with these infections is the added pressure to control costs and relieve the economic burden imposed on the health care system from treatment. Pharmacists are well positioned to apply antimicrobial stewardship principles and assume a leadership role in the management of patients with CABP and ABSSSI. This educational activity will provide pharmacists with an evidence-based approach to managing the treatment of patients with CABP and ABSSSI in accordance with Centers for Medicare & Medicaid Services criteria and clinical guidelines.
Learning Objectives
At the conclusion of this application-based educational activity, participants should be able to
- Review current evidence-based approaches for the management of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
- Explain a decision process for the selection of antimicrobial therapy in patients with CABP and ABSSSI.
- Discuss newer antimicrobials and their appropriate use while maintaining optimal efficacy and safety.
- Review the CMS criteria and clinical guidelines for the management of CABP and ABSSSI.
Faculty
John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair
Assistant Professor, Pharmacy Practice
Chicago State University College of Pharmacy
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
John Esterly, Pharm.D., BCPS (AQ-ID), is Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy (CSU-COP) and Infectious Diseases Pharmacist at Northwestern Memorial Hospital in Chicago, Illinois. In these roles Dr. Esterly practices as a clinical pharmacist, specializing in the area of infectious diseases. He is also an integral member of the Antimicrobial Stewardship Program at Northwestern Memorial Hospital.
Dr. Esterly received his Doctor of Pharmacy degree from the University of Illinois-Chicago College of Pharmacy. He completed a pharmacy practice residency with comprehensive pharmacy services at Mercy Hospital and Medical Center in Chicago, Illinois. Dr. Esterly then completed a two-year infectious diseases pharmacotherapy fellowship with the Midwestern University Chicago College of Pharmacy in conjunction with Northwestern Memorial Hospital and Rush University Medical Center in Chicago, Illinois. He is a board certified pharmacotherapy specialist with added qualifications in infectious diseases.
Dr. Esterly’s research interests include antimicrobial resistance, pharmacokinetics and pharmacodynamics of antimicrobials, and antimicrobial stewardship related outcomes. His work has been presented at several national meetings and has been published in peer-reviewed journals. He also serves as a peer reviewer for both infectious diseases and pharmacy medical journals.
Scott Bergman, Pharm.D., BCPS (AQ-ID)
Associate Professor
Southern Illinois University Edwardsville
Clinical Pharmacy Specialist and PGY2 Infectious Diseases Residency Program Director
St. John’s Hospital
Springfield, Illinois
Scott Bergman, Pharm.D., BCPS (AQ-ID), is Associate Professor, Department of Pharmacy Practice at Southern Illinois University Edwardsville and Adjunct Assistant Professor, Division of Infectious Diseases at Southern Illinois University (SIU) School of Medicine in Springfield. In this role he specializes in infectious diseases pharmacotherapy at the hospitals and clinics affiliated with the SIU School of Medicine.
Dr. Bergman received his Bachelor of Science degree in pharmaceutical sciences and his Doctor of Pharmacy degree in pharmaceutical sciences from South Dakota State University in Brookings. He completed residencies in both pharmacy practice and infectious diseases at West Virginia University Hospitals and School of Pharmacy in Morgantown, West Virginia.
Dr. Bergman is a residency preceptor for four different PGY1 programs affiliated with the School of Pharmacy and director of the PGY2 infectious diseases pharmacy residency at St. John’s Hospital in Springfield, Illinois.
Dr. Bergman recently completed his term as Central Region Director with the Illinois Council of Health-System Pharmacists (ICHP) and was the recipient of the New Practitioner Leadership Award from ICHP. He received the Merck Infectious Diseases Pharmacy Residency Award from the Society of Infectious Diseases Pharmacists. He has also received the Excellence in Innovation Award from the Illinois Pharmacists Association.
Neil A. Davis, Pharm.D.
Clinical Pharmacy Coordinator, Critical Care Specialist, and Antibiotic Stewardship Co-chair
Sentara Healthcare
Virginia Beach, Virginia
Neil A. Davis, Pharm.D., is Clinical Pharmacy Coordinator at Sentara Healthcare in Hampton Roads, Virginia, and Critical Care Clinical Pharmacy Specialist at Sentara Virginia Beach General Hospital in Virginia Beach. Dr. Davis is also Assistant Clinical Professor at the School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University in Richmond. In addition, he is Residency Program Director for the Sentara Healthcare Pharmacy Practice Residency.
Dr. Davis graduated from the University of Georgia College of Pharmacy in Athens, Georgia, and completed residencies in pharmacy practice and critical care at the Medical College of Virginia Hospitals. Dr. Davis specializes in the field of anti-infectives and participates in a variety of research and scholarly activities. He has published articles in several prestigious journals, and makes presentations throughout the country. He maintains active membership in numerous professional scientific and professional organizations, including the Society of Critical Care Medicine, the American Society of Health-System Pharmacists, the American College of Clinical Pharmacists, and the Virginia Society of Hospital Pharmacists.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
The faculty listed below report the following relationships pertinent to this activity:
- Neil A. Davis, Pharm.D., declares that he has served on the speakers bureau for Forest and Pfizer, Inc.
The following faculty and planners report no relationships pertinent to this activity:
- Scott Bergman, Pharm.D., BCPS (AQ-ID)
- John Esterly, Pharm.D., BCPS (AQ-ID)
- Erika L. Thomas, M.B.A., B.S.Pharm.
- Susan R. Dombrowski, M.S., B.S.Pharm.
ASHP Advantage staff have no relevant financial relationships to disclose.
This activity is supported by an educational grant from Forest Research Institute, a subsidiary of Forest Laboratories, Inc.
Agenda (120 minutes total)*
Introduction
John Esterly, Pharm.D., BCPS (AQ-ID), Activity Chair
(5 minutes)
Guideline-based Approach to the Management of CABP and ABSSSI
Neil A. Davis, Pharm.D.
(35 minutes)
New and Emerging Therapies for the Management of CABP and ABSSSI
John Esterly, Pharm.D., BCPS (AQ-ID)
(35 minutes)
Appropriate Management of CABP and ABSSSI: Balancing CMS Criteria with Clinical Guidelines and Stewardship
Scott Bergman, Pharm.D., BCPS
(35 minutes)
Questions and Answers
All Faculty
(optional, 10 minutes)
*Allow additional time to complete the assessment and evaluation.
Launch PresentationDownload Assessment and Handout
Print the assessment (post-test) and handout of slides for your reference; however, your assessment must be submitted online.
Process CE
When you reach the end of the activity, follow instructions to complete the online process (i.e., take assessment test and complete evaluation) and obtain CE credit.
Additional Resources
For additional education and resources about this topic or to sign-up to be notified when new resources are available, visit www.ashpadvantage.com/id.
Planned and coordinated by ASHP Advantage
